Henry Schein Stock

Henry Schein ROCE

The Return on Capital Employed (ROCE) of Henry Schein (HSIC) as of Aug 25, 2026 is 15.81 %. In the previous year, Return on Capital Employed (ROCE) was 15.07 % — a change of 4.91% (higher).

ROCE

15.81 %

YoY

4.91%

Last updated:

In 2026, Henry Schein's return on capital employed (ROCE) was 15.81 %, a 4.91% increase from the 15.07 % ROCE in the previous year.

The Henry Schein ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
17.99 USD
Jan 1, 2019
18.71 USD
Jan 1, 2020
13.16 USD
Jan 1, 2021
18.28 USD
Jan 1, 2022
20.08 USD
Jan 1, 2023
13.86 USD
Jan 1, 2024
15.07 USD
Jan 1, 2025
15.81 USD
The Henry Schein ROCE history
YEARROCEYoY
15.81 %+4.91%
15.07 %+8.77%
13.86 %-31.00%
20.08 %+9.85%
18.28 %+38.93%
13.16 %-29.67%
18.71 %+3.98%
17.99 %-23.91%
23.65 %-1.40%
23.98 %+6.96%
22.42 %+6.01%
21.15 %
Access this data via the Eulerpool API

Henry Schein Stock analysis

What does Henry Schein do? Henry Schein Inc is a global provider of medical products and services for the healthcare industry based in Melville, New York. It was founded in 1932 by Henry Schein and has a long history of providing high-quality products and services for the healthcare industry. The company specializes in four core areas: medical products, services, medical software, and veterinary products. In the medical products area, Henry Schein distributes a wide range of medical products and equipment, including dental and orthodontic products, surgical instruments and supplies, medical laboratory equipment and supplies, and furnishings for practices. The company strives to offer its customers the best selection of medical products at a competitive price. Henry Schein also offers services aimed at making the work of healthcare providers easier. For example, the company provides services such as practice management software, online pharmacies, insurance, and billing services to optimize the operation of a medical or veterinary practice. Another important area of the company is medical software. Henry Schein offers an extensive range of software solutions for medical and veterinary practices, as well as hospitals and other medical facilities. The software facilitates tasks such as electronic medical records, appointment scheduling, and financial management, enabling practices and hospitals to operate more efficiently. Henry Schein has also specialized in the field of veterinary medicine, offering a wide range of products and services for veterinarians and animal clinics. The company distributes veterinary instruments, laboratory equipment, surgical instruments, and veterinary medications, and also provides services such as practice management software and veterinary billing. The company aims to provide its customers with a comprehensive range of products and services in a variety of areas. Henry Schein has established itself as an industry leader and is valued for its high quality and excellent customer service. Henry Schein is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Henry Schein's Return on Capital Employed (ROCE)

Henry Schein's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Henry Schein's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Henry Schein's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Henry Schein’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Henry Schein stock

Return on Capital Employed (ROCE) of Henry Schein is 15.81 % in 2026.

Return on Capital Employed (ROCE) of Henry Schein changed from 15.07 % to 15.81 %, representing a 4.91% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Henry Schein since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Henry Schein with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

Profitability — Henry Schein

All Key Metrics — Henry Schein